endpoint launches ConnectionPOINT ™, a collaborative program designed to drive accelerated outcomes and advance medicine through the interconnection of next-generation eClinical technologies endpoint launches ConnectionPOINT ™, a collaborative program designed to drive accelerated outcomes and medicine advance through state-of-the-art interconnection eClinical technologies
PR Newswire
SAN FRANCISCO, April 21, 2021
SAN FRANCISCO, April 21, 2021 / PRNewswire / – endpoint Clinical, the world’s leading interactive response technology (IRT®) company, today announced the launch of its collaborative ConnectionPOINT ™ program, the first of its kind in the field of eClinical technology. The vision of the program is to achieve guided convergence of a select network of eClinical providers who are innovation leaders in their fields and committed to driving the shift towards a smarter next-generation interface.
“While this is our official launch of a collaborative program, we’ve been working with the best eClinical technology providers for over a decade to help transform the future of drug development,” said Ryan Keane, director of endpoint operations. “What we’ve learned from our commitment to building relationships and building technology for so long is that together we can look further to move the industry forward and also have the real ability to achieve those common goals and then move forward. ConnectionPOINT is the This gives sponsors the peace of mind that traditionally disparate systems across multiple eClinical vendors can not only communicate seamlessly with each other, but also push boundaries with data rates and efficiency that don’t exist anywhere in the current eClinical ecosystem ”.
ConnectionPOINT’s main mission is to promote a sustainable and scalable infrastructure within a network of strong and verified alliances that support business and eClinical technology, based on the principles of creating opportunities, driving innovation and harmonizing services across the whole ecosystem.
One of the most compelling uses for these strategic alliances is to strengthen the alignment between technology and service lines that are often perceived as independent, essential in their own right and with historic common intersections, but are now poised to generate new disruptive opportunities. Here’s what some of the endpoint partners say about the already recognized benefits of ConnectionPOINT and the performance of their existing technology that interfaces with the endpoint IRT:
“When TSS and endpoint came together to explore what our companies could achieve together in our field, we immediately realized that it was possible to achieve more than the simple realizations of legacy touchpoints such as basic shipment monitoring,” he said. Evan Hahn, Vice President for North America for TSS, a leading global provider of temperature monitoring technologies and services. “All conversations at all levels between endpoint and TSS, from CEOs to technical SMEs and business development, quickly reflected the idea of how far we can go and prepare this part of the ecosystem for the changes taking place in the industry and the great need to share data and functionality around temperature monitoring in real time. It was clear that the endpoint and TSS would quickly gather the expected practical basis of an integrated approach. The next step would be to move forward with the next generation of real-time dual integration. track that goes beyond the shipping level to the item level, applies both to central inventory and standard shipping needs, and is ready to work across all boundaries where wireless surveillance technology opens up this space. That’s exactly what we did. Going to a goal is not possible without both organizations is very aligned. “
“One of the direct data collection (DDC) options in encapsia®, eSource DDC represents an important opportunity for the industry as a standalone alternative, but the main benefit is to bring simplicity to the complex ecosystem of technologies and services of Encapsia®. clinical trials. To this end, more than two and a half years ago, we leveraged the dynamic encapsia architecture with the hyperintegration endpoint approach in a concerted effort to closely interconnect systems across a spectrum of expertise for both schools and studio managers. ” , Said Temitope Keyes, CEO of Cmed Technology. “The encapsulation and endpoint teams have demonstrated a deep commitment to partnership, customer success, technological innovation and thoughtful industry leadership, driving our mutual ability to deliver a highly harmonized set of systems along with We provide an intuitive and efficient clinical supplies and workflows for clinical operations, always in compliance and using dynamic data in near real time. ”
The spectrum of possibilities can range from deep product interconnection to new business models and requires all of the above.
“The tools and systems built by our industry are often very protocol-specific and driven by sponsorship needs. As a result, plants are often provided with numerous applications to learn, as well as credentials. Partners to manage and remember,” said Rick Malone, McCreadie Group Business Development Executive. “We are looking for solutions that give drug research teams the flexibility to perform their preferred workflow tasks while meeting the specific sponsorship needs for each protocol. We are delighted to partner with a like-minded partner. center and sponsorship needs through our groundbreaking integration as a win for all parties involved. McCreadie Group and endpoint have spent over a year developing a solution that makes it easy for them to live to the centers while increasing speed and provide data integrity to sponsors. “
“While it is a promise to leverage the collective experience, strengths and clear benefits of direct interaction between partners, we recognize that it is also challenging for those who join this collective,” said Vincent Puglia, Senior Director of Partnerships. Endpoint strategies. “Constantly communicating, deepening conversations, breaking down barriers, considering new business models and tirelessly asking ‘what next?’ And what else can we do? ”“ It’s a significant commitment. It won’t be for everyone, but for those adopting a mission like ConnectionPOINT, the quality of the results cannot be underestimated. ”
Extra information
Visit our website for more information about the Endpoint ConnectionPOINT program.
Connect to the endpoint on LinkedIn
About end point
endpoint is a provider of interactive response technology (IRT®) systems and solutions that specialize in the life sciences industry. Over the past decade, his team of customer-focused professionals has continuously developed its suite of technologies to help sponsors achieve good results in their clinical trials. PULSE®, your dynamic IRT solution for patient, plant and drug supply randomization and management, and DRIVE, the innovative clinical inventory management tool, have been shown to optimize supply chain and minimize operating costs, enabling timely and accurate delivery of the drug for the patient is guaranteed. endpoint is headquartered in San Francisco, California, in addition to other offices in the United States, the European Union, and Asia. www.endpointclinical.com
Contacts:Catherine Ditzler Associate Director Marketing Endpoint Clinical 1-415-688-3424 Email: [email protected]
Photo: https://mma.prnewswire.com/media/1492520/endpoint_Clinical_Launches_ConnectionPOINT.jpg
SOURCE endpoint Clinical